« Previous
Next »
Titles
- Brand name drug prices increase more than twice as fast as inflation in 20181
- One percent of drugs with Medicaid reimbursement were not FDA-approved1
- Price decreases for widely used generic drugs slow in 2017 after two years of substantial price drops1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis1
- Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 20151
- Rx price watch report: price growth for brand name and specialty drugs more than offset price decrease for generic drugs1
- Rx price watch report: specialty prescription drug prices continue to climb1
- Status of U.S. health insurance coverage and the potential of recent congressional health reform bills to expand coverage and lower consumer costs: invited testimony : U.S. House of Representatives, Committee on Rules : hearing on "Medicare for All Act of 2019"1
- Trends in retail prices of generic prescription drugs widely used by older Americans: 2017 year-end update1
- Trends in retail prices of prescription drugs widely used by older Americans: 2017 year-end update1
- Trends in retail prices of specialty prescription drugs widely used by older Americans: 2017 year-end update1
- Utilization and spending trends in Medicaid outpatient prescription drugs1